| Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
|---|
| 01/15/2002 | US6339154 (2-Substituted oxyphenyl) alkanamide derivative, hair growth promoter and external composition for skin using the same |
| 01/10/2002 | WO2002002684A1 Stabilisers, in particular for thermoplastic polyurethanes |
| 01/10/2002 | WO2002002520A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002518A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002513A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002509A1 Compounds and compositions for delivering active agents |
| 01/10/2002 | WO2002002506A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002505A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2001023346A3 Process for phenylacetic acid derivatives |
| 01/10/2002 | US20020004522 Nervous system disorders |
| 01/10/2002 | US20020004503 Viricides |
| 01/10/2002 | CA2414881A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | CA2410972A1 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2410680A1 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
| 01/09/2002 | EP1170290A2 Compounds having ultra-violet absorption properties |
| 01/09/2002 | EP1170289A2 Retroviral protease inhibiting compounds |
| 01/09/2002 | EP1170275A2 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application |
| 01/09/2002 | EP1169393A1 Acetoacetylarylide suspensions in pigment applications |
| 01/09/2002 | EP1169300A1 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof |
| 01/09/2002 | CN1330631A Amide derivatives which are useful as cell factor inhibitors |
| 01/09/2002 | CN1330630A 7-aryl-6(z) heptantriene acid vitamin A amide as apoptosis inducing compounds and their use as anti-cancer agents |
| 01/08/2002 | US6337350 Inhibitors of formation of advanced glycation endproducts (AGEs) |
| 01/03/2002 | WO2002000607A1 Amide compounds and use thereof |
| 01/03/2002 | US20020002296 Cytoprotective Compounds |
| 01/03/2002 | US20020002290 Calixarenes and their use for sequestration of metals |
| 01/03/2002 | US20020001591 Compositions for the delivery of antigens |
| 01/03/2002 | DE10030880A1 3,4-Dihydroxymandelsäurealkylamide und ihre Verwendung 3,4-dihydroxymandelic acid alkylamides and their use |
| 01/02/2002 | EP1167364A1 Benzopyran-containing compounds and prodrug forms thereof |
| 01/02/2002 | EP1167346A1 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient |
| 01/02/2002 | EP1165502A1 Diaryl derivatives and their use as medicaments |
| 01/02/2002 | EP1165495A1 Resorcinol derivatives |
| 01/02/2002 | EP1165494A2 Hsv primase inhibitors |
| 01/02/2002 | EP1165487A1 Derivatives of venlafaxine and methods of preparing and using the same |
| 01/02/2002 | EP1165064A2 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 01/02/2002 | EP1164846A1 Prostaglandin compounds, compositions and methods of treating peripheral vascular disease and pulmonary hypertension |
| 01/01/2002 | CA2093789C Bi-aromatic compounds and their use in human and veterinary medicine and in cosmetic preparations |
| 12/27/2001 | WO2001098258A1 3,4-dihydroxymandelic acid alkylamides and use thereof |
| 12/27/2001 | WO2001098257A1 NOVEL β-HYDROXYAMIDES |
| 12/27/2001 | WO2001098256A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 12/27/2001 | WO2001098248A2 Hiv integrase inhibitors |
| 12/27/2001 | WO2001098245A2 Triphenyl compounds as interleukin-4 antagonists |
| 12/27/2001 | WO2000067626A3 Oat extracts: refining, compositions and methods of use |
| 12/27/2001 | US20010056211 Adrenergic blocking agent |
| 12/27/2001 | US20010056152 Chlorinated vinyl chloride resin composition |
| 12/27/2001 | US20010056113 Methods for the inhibition of angiogenesis with 6-amino EM-12 |
| 12/27/2001 | US20010056107 Cyano and carboxy derivatives of substituted styrenes are inhibitors of tumor necrosis factor alpha , nuclear factor kappa B, and phosphodiesterase and can be used to treat cachexia, endotoxic shock, inflammatory conditions etc. |
| 12/27/2001 | CA2412985A1 Hiv integrase inhibitors |
| 12/25/2001 | US6333432 Fungicidal compositions and methods, and compounds and methods for the preparation thereof |
| 12/25/2001 | US6333426 Chiral adsorbents and preparation thereof as well as compounds on which the absorbents are based and preparation of the compounds |
| 12/25/2001 | US6333358 Aryloxyaniline derivatives |
| 12/20/2001 | WO2001096293A1 Vitamin d derivatives |
| 12/20/2001 | WO2001096283A2 Hiv integrase inhibitors |
| 12/20/2001 | US20010053863 Curable allyl homopolymer |
| 12/20/2001 | CA2412857A1 Hiv integrase inhibitors |
| 12/19/2001 | EP1163209A1 Compounds and compositions for delivering active agents |
| 12/19/2001 | EP1163208A2 Caspase inhibitors and uses thereof |
| 12/19/2001 | EP0762830B1 Method for enhancing the efficacy of agricultural chemicals |
| 12/19/2001 | CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 12/19/2001 | CN1076341C Selective nitration o phenol derivatives |
| 12/18/2001 | US6331640 Diaminopropionic acid derivatives |
| 12/18/2001 | US6331627 Intermediates of benzoxazinone derivatives and preparation thereof |
| 12/18/2001 | US6331570 Active enantiomer of RARγ-specific agonist |
| 12/18/2001 | US6331542 Protease inhibitors |
| 12/18/2001 | US6331318 Carbon-substituted diketopiperazine delivery systems |
| 12/13/2001 | WO2001094295A1 Substituted stilbenes as glucose uptake enhancers |
| 12/13/2001 | WO2001094293A2 Benzamide ligands for the thyroid receptor |
| 12/13/2001 | WO2001068599A3 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
| 12/13/2001 | US20010051657 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 12/13/2001 | CA2411340A1 Substituted stilbenes as glucose uptake enhancers |
| 12/13/2001 | CA2411062A1 Benzamide ligands for the thyroid receptor |
| 12/12/2001 | EP1161421A1 Inhibitors of protein tyrosine phosphatase |
| 12/12/2001 | EP1161412A1 Nuclear receptor arylating compounds |
| 12/12/2001 | EP1161233A2 Lxr modulators |
| 12/12/2001 | EP0966431B1 Salicylic acid-sphingoid base derivatives and uses thereof |
| 12/12/2001 | EP0869941B1 Modified polyunsaturated fatty acids |
| 12/12/2001 | EP0781126B1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system |
| 12/12/2001 | CN1325847A Compound with electron providing and receiving functional groups |
| 12/12/2001 | CN1325844A Process for synthesizing (+/-)p-fluoro-2(2-methyl-propionyl)-4-oxy-N,3-diphenyl-phenylbutylamide |
| 12/11/2001 | US6329377 Enzyme inhibitors for nervous system disorders |
| 12/06/2001 | WO2001092273A2 Benzenedicarboxylic acid derivatives |
| 12/06/2001 | WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents |
| 12/06/2001 | WO2001092206A1 Method of preparing salicylamides |
| 12/06/2001 | WO2001092201A1 Substituted phenylpropionic acid derivatives |
| 12/06/2001 | CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 12/05/2001 | EP1159265A1 C-16 unsaturated fp-selective prostaglandins analogs |
| 12/05/2001 | EP1159260A1 Novel compounds and compositions as protease inhibitors |
| 12/05/2001 | EP1159255A2 Bis(1,3-dihydroxy-prop-2-yl)amine and derivatives thereof in the manufacture of polymers |
| 12/05/2001 | EP0937036B1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors |
| 12/05/2001 | CN1325380A Benzene derivatives and medical use thereof |
| 12/05/2001 | CN1325376A Novel compounds and medicinal use thereof |
| 12/04/2001 | US6326479 Synthetic polymers and methods, kits or compositions for modulating the solubility of same |
| 12/04/2001 | US6326398 Oxamic acids and derivatives as thyroid receptor ligands |
| 12/04/2001 | US6326369 Bicyclic quinone compounds, their production and use |
| 11/29/2001 | WO2001090052A1 Cyclic amino acid derivatives useful as pharmaceutical agents |
| 11/29/2001 | US20010046975 Fungicides for the control of take-all disease of plants |
| 11/29/2001 | CA2409768A1 Cyclic amino acid derivatives useful as pharmaceutical agents |
| 11/28/2001 | EP1157002A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy |
| 11/28/2001 | EP1157001A1 Oxamic acids and derivatives as thyroid receptor ligands |